Regeneron Pharmaceuticals, Inc. (REGN)
775.10
+11.87
(+1.56%)
USD |
NASDAQ |
Jan 06, 15:46
Regeneron Pharmaceuticals Research and Development Expense (Annual): 4.624B for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amgen, Inc. | 5.676B |
| Gilead Sciences, Inc. | 5.816B |
| Johnson & Johnson | 17.26B |
| Eli Lilly & Co. | 10.99B |
| Merck & Co., Inc. | 15.79B |